Home 2020 COVID-19: “There is no benefit to gain-of-function research, but plenty of risk”

COVID-19: “There is no benefit to gain-of-function research, but plenty of risk”


#PresidentTrump #COVID19 #bioterrorism

Scientific experts worldwide have insisted that in the early days of the “pandemic” that SARS-CoV-2 did not originate in a lab, while behind the scenes they were debating on whether to discuss that as a real possibility.

Recently e-Mails obtained through Freedom of Information Act (FIA) requests by US Right to Know (US RTK) not only reflect those debates and conversations, but spell out how the scientists worked to cover up any suggestions that COVID-19 originated in a lab.

Not only that, the e-Mails detail strategies for discounting lab origin ideas, what they referred to as “fringe” theories that the virus originated in a lab rather than in wildlife.

With building evidence, US researchers and public health authorities may face life in prison for their involvement in the virus, the penalty for bioterrorism under the Anti-Terrorism Act   There is no benefit to gain-of-function research, but plenty of risk.

Dr. Fauci and his cohorts are targets, and remember that Donald Trump is the President and that he has a reputation for taking no prisoners/

Stay tuned…

Making and Keeping America Great!

Have a healthy day, Keep the Faith!

Previous articleApple (NASDAQ:AAPL) Stock Could Gain 32% in 2021
Next articleAmazon (NASDAQ:AMZN) HEFFX Technical Analysis and Charts
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.